The patch: not just for nicotine addicts anymore.
Gaithersburg-based biotech company Iomai Corp. announced Tuesday it was receiving a small grant, just under $1 million, from the U.S. Army Medical Research and Material Command for work on a patch-based anthrax vaccine.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.